Shalby Global Tech, Singapore bags regulatory approval for implants, medical devices

SGT can import the said implants and medical devices from the US and sell them in Indonesia

Shalby’s step-down subsidiary Shalby Global Technologies (SGT), Singapore has received regulatory approval to market and sell knee implants, hip systems, knee and hip instruments, etc. from the Ministry of Health, Indonesia. Now, SGT can import the said implants and medical devices from the US and sell them in Indonesia.

The development is fully in line with the stated strategy to grow the implant business and establish a footprint in the medical device market internationally. This is a big milestone achieved by the Shalby group in its journey to serve many more international patients. The synergies between the businesses are compelling and will bring immediate benefits of sourcing US FDA-approved quality implants into Indonesia through our distribution channels.

Shalby has performed more than 1,44,000 joint replacement surgeries so far and continues to be the leader in India and globally in terms of the volume of surgeries performed annually.